Scientific trial workflow platform OneStudyTeam, a Reify Well being firm, has laid off 160 staff, or roughly 25% of its workforce.
“We are able to affirm that we made the very tough choice to let a few of our crew members go. Every particular person performed a task in constructing OneStudyTeam, and we’re grateful for his or her contribution to our mission of accelerating the event of lifesaving therapies for sufferers. We concluded that we have to restructure our crew going into 2023 to streamline operations after a interval of extraordinarily fast development and hiring,” an organization spokesperson informed MobiHealthNews in an e mail.
THE LARGER TREND
In November, OneStudyTeam introduced a partnership with New York-based Antidote Applied sciences to supply one platform for scientific trial sponsors, websites and individuals. The platform would make the most of OneStudyTeam’s cloud-based software program often called StudyTeam, in addition to Antidote’s patient-engagement platform.
In April, OneStudyTeam’s mother or father firm Reify garnered $220 million in Collection D funding, boosting the corporate’s valuation to $4.8 billion.
That spherical got here lower than a yr after the corporate raised $220 million in Collection C funding. The corporate additionally introduced in $30 million in Collection B financing in 2020.
